How many units of Svetinorm should I draw?

It depends on your vial size, BAC water, and dose. For a 20mg vial with 0mL BAC water, a beginner dose of 10mg is typically 0 units on a U-100 syringe. Use the calculator above for your exact numbers.

How much BAC water should I add to Svetinorm?

The standard amount is 0mL of bacteriostatic water for a 20mg vial. More water gives a more dilute solution — easier to measure small doses. Less water means fewer injections per vial. Adjust the BAC water slider in the calculator to see how it changes your syringe units.

How long does a Svetinorm vial last?

At a beginner dose of 10mg daily, a 20mg vial lasts about 2000 doses. The calculator shows exact doses per vial for your selected tier.

What syringe should I use for Svetinorm?

Most people use a U-100 insulin syringe (1mL / 100 units). For very small doses, a U-50 or U-30 syringe gives better precision. The calculator adjusts units automatically for whichever syringe you pick.

Svetinorm Dosage Calculator

MetabolicOralResearch~0.5-1 hour half-life

Svetinorm is an oral peptide bioregulator developed by Prof.

May support liver protein synthesis and hepatocyte renewal (preclinical data)Stabilization of ALT and bilirubin observed in a small clinical studyProposed reduction in inflammatory markers (IgM) during liver diseaseSupports phase I and phase II liver detoxification enzyme expression (in vitro)4 weeks on / 16 weeks off

Vial Size

BAC Water (mL)

Dosing Level

10mcg · Daily

Custom Dose (mcg) — optional

Syringe Type

0.0 units

100 units (1mL)

Concentration

mcg/mL

Draw Volume

< 0.001

Syringe Units

< 0.1

units

Doses / Vial

doses

Summary: Add 0mL BAC water to your 20mg vial. Draw to < 0.1 units on a U-100 syringe for a 10mcg dose. This vial will last 0 doses.

Cycle Planner

Cycle Length (weeks)

Price Per Vial ($) — optional

Oral. Typical beginner frequency: daily.

Svetinorm Pharmacokinetics

Pharmacokinetics — Active Dose Over Time

t½ = ~0.5-1 hour (estimated from tetrapeptide class)

After 1 half-life (3h): 50% remainsAfter 2 half-lives (6h): 25% remainsAfter 3 half-lives (9h): 12.5% remains

At a 10mcg dose: 50% = 5mcg remaining after 3h. Recommended frequency: 2x Daily.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.

Svetinorm Dosing Protocol

Level	Dose / Injection	Frequency
Beginner	10mg	Daily
Moderate	10mg	2x Daily
Aggressive	20mg	2x Daily

Note: Khavinson liver peptide bioregulator containing peptide complex A-7 extracted from young animal liver tissue. Oral capsules — no reconstitution needed. Standard course is 1-2 capsules, 1-2 times daily with meals for 20-30 days. Repeat 2-3 times per year. Very limited Western clinical data.

About Svetinorm

Svetinorm is an oral peptide bioregulator developed by Prof. Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It contains peptide complex A-7 — a mixture of low-molecular-weight peptides (under 10 kDa) extracted from the liver tissue of young calves. The active component is believed to include or relate to the tetrapeptide KEDA (Lys-Glu-Asp-Ala), also known as Livagen, which has shown tissue-specific affinity for hepatocytes in preclinical studies. Svetinorm is designed to restore protein synthesis in aging or damaged liver cells by interacting with DNA promoter regions and activating gene transcription. A small clinical study at Khavinson's institute (2003-2004) enrolled patients with chronic hepatitis and post-chemotherapy liver damage. Those receiving Svetinorm alongside standard treatment showed stabilized ALT (alanine aminotransferase) and bilirubin levels, along with decreased IgM — a marker of inflammatory activity. The researchers concluded it had hepatoprotective properties suitable for chronic liver disorders and post-radiation recovery. However, the evidence base is narrow: most data comes from a single Russian research group, no randomized controlled trials have been published in Western journals, and the exact peptide composition of A-7 isn't publicly disclosed. Users should consider Svetinorm an experimental bioregulator with promising but unconfirmed hepatoprotective potential.

View full Svetinormguide →Add to schedule →